News

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...
Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...
Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...
Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...
The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...
Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.
Prostate cancer is the most common cancer in men worldwide. Thanks to scientific breakthroughs, there are more ways than ever to treat it — especially when it’s caught early. One ...
Batoul Al Balooshi, Assistant Professor of Nuclear Medicine at Mohammed Bin Rashid University of Medicine and Health Sciences ...
Pedro C. Barata, MD, MSc, discusses the use of darolutamide in patients with hormone-sensitive prostate cancer.
As many men delay seeing a doctor out of embarrassment, a number of non-invasive tests for prostate and testicular cancer are on the horizon that are even more accurate in detecting the disease in ...
Pfizer advances bold vision for future of cancer care at the ASCO 2025 annual meeting: New York Friday, April 25, 2025, 10:00 Hrs [IST] Pfizer Inc. will showcase data across its p ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.